Van Vuuren, Anneke J.

Publishing since 2005 (Junior)

Has published 9 publications in 6 years

Number of publications published per year by Van Vuuren, Anneke J.. (Source : PubMed)

Distribution of publications types for Van Vuuren, Anneke J.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59;1
Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br. J. Cancer 2009;100;7
Mensink PB, Hol L, Borghuis-Koertshuis N, Geelkerken RH, Huisman AB, Doelman CJ, van Vuuren AJ, Kuipers EJ, Kolkman JJ. Transient postprandial ischemia is associated with increased intestinal fatty acid binding protein in patients with chronic gastrointestinal ischemia. Eur J Gastroenterol Hepatol 2009;21;3
Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology 2008;135;2
De Vries AC, Van Driel HF, Richardus JH, Ouwendijk M, Van Vuuren AJ, De Man RA, Kuipers EJ. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries. Scand. J. Gastroenterol. 2008;43;4
Kerkhof M, Steyerberg EW, Kusters JG, van Dekken H, van Vuuren AJ, Kuipers EJ, Siersema PD. Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus. Cancer biomarkers : section A of Disease markers 2008;4;1
Mulder SA, van Leerdam ME, van Vuuren AJ, Francke J, van Toorenenbergen AW, Kuipers EJ, Ouwendijk RJ. Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer. Eur J Gastroenterol Hepatol 2007;19;10
Kerkhof M, Bax DA, Moons LM, van Vuuren AJ, van Dekken H, Steyerberg EW, Kuipers EJ, Kusters JG, Siersema PD. Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells? Aliment. Pharmacol. Ther. 2006;24;11-12
van Vuuren AJ, van Roon JA, Walraven V, Stuij I, Harmsen MC, McLaughlin PM, van de Winkel JG, Thepen T. CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model. J. Immunol. 2006;176;10
De Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW. Pharmacogenetics of thiopurine therapy in paediatric IBD patients. Aliment. Pharmacol. Ther. 2006;23;8

[ See timeline ] [ See all publications ]

Key figures

9 pub in 6 years
1.5 publications/year
best year 2008 with 3 pub
h-index 0 with 9 pub
h-ratio : 0 %

See Timeline

Ranking

It's me !

Click here if you are
Van Vuuren, Anneke J..

Most frequent Journals

Gut (2x)
Aliment. Pharmacol. Ther. (2x)
Eur J Gastroenterol Hepatol (2x)
EMBO J. (2x)
Scand. J. Gastroenterol. (1x)

Main affiliation

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.

Latest co-workers

De Vries AC Feinman SV Geelkerken RH Habbema JD Hol L Huisman AB Kuipers EJ Kusters JG Mulder SA Ouwendijk M Reijerink JC Richardus JH Schutten M Stuij I Trojan J van Ballegooijen M van Dekken H van Leerdam ME van de Winkel JG van der Togt AC

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.